Loading...
•
Mar 31, 2025
Definitive Healthcare Q1 2025 Earnings Report
Reported Financial Results for First Quarter Fiscal Year 2025
Key Takeaways
Definitive Healthcare reported Q1 2025 financial results with revenue exceeding guidance, despite a 7% decrease year-over-year. The company posted a significant net loss due to goodwill impairment charges but achieved positive unlevered free cash flow.
Revenue for Q1 2025 was $59.2 million, a 7% decrease compared to Q1 2024.
Net loss for Q1 2025 was $(155.1) million, including $176.5 million in goodwill impairment charges.
Adjusted EBITDA was $14.7 million, representing a 25% margin.
Unlevered Free Cash Flow was $22.9 million in the quarter.
Forward Guidance
For Q2 2025, revenue is expected between $58.5 million and $60.0 million, Adjusted Operating Income between $12.0 million and $13.0 million, Adjusted EBITDA between $15.0 million and $16.0 million (25-27% margin), and Adjusted Net Income Per Diluted Share between $0.04 and $0.05. For the full year 2025, revenue is expected between $234.0 million and $240.0 million, Adjusted Operating Income between $49.0 million and $53.0 million, Adjusted EBITDA between $61.0 million and $65.0 million (26-28% margin), and Adjusted Net Income Per Diluted Share between $0.20 and $0.23.
Positive Outlook
- Q1 results exceeded the high end of guidance for both revenue and earnings.
- Solid new logo momentum across markets.
- Continued focus on operational efficiency.
- Remaining on track to meet full-year financial targets.
- Raising the bottom end of the full-year revenue guidance range.
Challenges Ahead
- Rising macroeconomic uncertainty mentioned.
- No quantitative reconciliation of forward-looking non-GAAP measures provided due to high variability.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...